Sep 28, 2023 / 01:00PM GMT
Presentation
Sep 28, 2023 / 01:00PM GMT
=====================
Corporate Participants
=====================
* David Simon Redfern
GSK plc - President of Corporate Development
* Deborah Jayne Waterhouse
GSK plc - CEO of ViiV Healthcare & President of Global Health
* Kimberly Smith
ViiV Healthcare Limited - Head of Global Research & Medical Strategy
* Nick Stone
=====================
Conference Call Participants
=====================
* Andrew Simon Baum
Citigroup Inc., Research Division - Global Head of Healthcare Research and MD
* Emmanuel Douglas Papadakis
Deutsche Bank AG, Research Division - Research Analyst
* Eric Le Berrigaud
Stifel, Nicolaus & Company, Incorporated, Research Division - Research Analyst
* Graham Glyn Charles Parry
BofA Securities, Research Division - MD and Head of Healthcare Equity Research
* James Daniel Gordon
JPMorgan Chase & Co, Research Division - Senior Analyst
* Kerry Ann Holford
Joh. Berenberg
GSK PLC
(OTCPK:GLAXF)
$
25.33
-1.493 (-5.57%)
Market Cap: 104.62 Bil
Enterprise Value: 117.42 Bil
PE Ratio: 13.93
PB Ratio: 4.47
GF Score: 75/100 GSK plc Getting ahead of HIV with ViiV Management Presentation Transcript
Sep 28, 2023 / 01:00PM GMT
Release Date Price:
$18.26
(-1.00%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot